RecruitingNot ApplicableNCT05677022
Evaluation of the Interest of a Postural and Functional Analysis for the Follow-up of the Adapted Motor Activity of Patients Treated for Breast Cancer
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Enrollment
60 participants
Start Date
Feb 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to evaluate the acceptability by patients treated for breast cancer of an adapted motor activity program over a period of 15 months controlled by a postural and functional analysis.. Participant population/health conditions: patients with newly operated breast cancer who are candidates for an adapted physical activity program
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria3
- Adult woman, having given her consent to participate in the study,
- Patient with non-metastatic breast cancer,
- Cancer to be treated by surgery with or without adjuvant treatment (radiotherapy and/or chemotherapy).
Exclusion Criteria5
- Contraindication to the practice of a physical activity,
- Mental deficiency or any other reason that could hinder the understanding or the strict application of the protocol,
- Patient not affiliated to the French social security system,
- Patient under legal protection, guardianship or curatorship,
- Patient already included in another therapeutic study protocol aimed at evaluating the benefits of adapted physical activity.
Interventions
OTHERAdapted motor activity
15-month adapted motor activity program based on a postural and functional analysis
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05677022
Related Trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
NCT052915071 location
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT041190243 locations
Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia
NCT0693085934 locations